​

If you are a researcher or a physician and you would like to join our mission of curing PACS2 syndrome - reach out to us: pacs2research@gmail.com

--

 

Available assets

• Fibroblasts (1 cell line with mutation + controls from a fraternal twin and parents) - Coriell Institute (US)

• Fibroblasts (4 cell lines + 2 controls from siblings) - Medical University of Warsaw (Europe)

• iPSC (1 line) - WiCell (developed in cooperation with iXCells Biotechnologies)

• Mouse model with PACS2 mutation - available in: Czech Academy of Science (first developed line); University of Bialystok

• [Work in progress] Humanized mouse model development - The Jackson Laboratory

• Current publications on PACS2 Syndrome listed under this link

​

On-going & planned research run in cooperation with the Foundation:
Basic research

• Metabolic profiling of fibroblasts (extended by proteomic analysis) - Nencki Institute of Experimental Biology (Poland)
  Leading investigators: prof. Agnieszka Dobrzyn, prof. Mariusz Wieckowski

• Clinical observation of 4 new cases  - Medical University of Warsaw, Medical University of Wroclaw (Poland)
  Leading: Sylwia Czarnecka, MMSc; under supervision of prof. Robert Smigiel and Krzysztof Szczaluba, PhD

• Characterization of iPSC-derived neural cells to understand PACS2 syndrome - Northwestern University (Chigaco, US)
  Leading investigator: Alicia D Guemez Gamboa, PhD 

• PACS2 E209K mouse model phenotyping - University of Bialystok (Poland)
  Leading investigators: Kacper Łukasiewicz, PhD, Dominik Cysewski, PhD

• 3D model of mutated protein / structural biology - in plan / looking for a Partner

​

Translational research

• Towards therapeutic intervention in PACS2 syndrome with drug repurposing - Captor Therapeutics (Switzerland/Poland)

• Drug screening in C.elegans model -  Institute of Biochemistry and Biophysiscs Polish Academy of Science (Poland)

• Drug screening based on cell painting - Charles River Laboratories (Netherlands) -> progress update

• RNA editing - technology exploration for PACS2 mutation - University of Oxford (UK)

• Drug screening based on neuronal cells - in plan / looking for a Partner

​

Clinics​

• Patient registry - Simons Searchlight - to be started soon

• Natural History Study - under preparation - Partners to be announced soon

​

Other on-going research:

• Role of PACS2 in central nervous system myelination - State University of New York at Buffalo
  Leading investigator: Yungki Park, PhD

​

If you are a researcher or physician, you run a research around PACS2 mutation and you would like to list your research above - please let us know: pacs2research@gmail.com.